The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers

Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers

(2012) Ziva D. Cooper et al.   BEHAVIOURAL PHARMACOLOGY

Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains

(2011) Liang Liu et al.   BRAIN BEHAVIOR AND IMMUNITY

A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: A mixed treatment comparison meta-analysis

(2010) Nicholas Meader   DRUG AND ALCOHOL DEPENDENCE

Abuse liability of oxycodone as a function of pain and drug use history

(2010) S.D. Comer et al.   DRUG AND ALCOHOL DEPENDENCE

The pharmacological treatment of opioid addiction—a clinical perspective

(2010) Philipp Lobmaier et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?

(2010) F. Barkhof et al.   NEUROLOGY

The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release

(2009) Sondra T. Bland et al.   BRAIN BEHAVIOR AND IMMUNITY

Opioid dependence treatment: options in pharmacotherapy

(2009) Angela L Stotts et al.   EXPERT OPINION ON PHARMACOTHERAPY

Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease

(2009) P Rolan et al.   EXPERT OPINION ON PHARMACOTHERAPY

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia

(2008) Mark R. Hutchinson et al.   BRAIN BEHAVIOR AND IMMUNITY

Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)

(2008) Mark R. Hutchinson et al.   BRAIN BEHAVIOR AND IMMUNITY

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

(2008) Paul Rolan et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆

(2008) E YU et al.   DRUG AND ALCOHOL DEPENDENCE

Mechanisms of Withdrawal-Associated Increases in Heroin Self-Administration: Pharmacologic Modulation of Heroin vs Food Choice in Heroin-Dependent Rhesus Monkeys

(2008) S Stevens Negus et al.   NEUROPSYCHOPHARMACOLOGY